Partial arch replacement for type A aortic dissection with cold agglutinin disease after sutimlimab

Tatsuya Ozaki1, Taro Nakazato1, Koji Hashimoto2

  • 1Department of Cardiovascular Surgery, Kansai Rosai Hospital, Hyogo, Japan.

PubMed
Summary

Sutimlimab effectively managed cold agglutinin disease (CAD) in a patient undergoing aortic surgery with hypothermic circulatory arrest. This approach prevented hemolysis, allowing for an uneventful recovery and discharge.